[1]
T. Bal and M. Cabalak, “Sofosbuvir and Ribavirin in Turkish non-cirrhotic chronic hepatitis C patients infected with genotype 2 or 3 ”, annalsmedres, vol. 27, no. 8, pp. 2067–2071, May 2021.